Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

Fold changes were calculated as mean condition B/mean condition A, after mTIC normalization. by Manuel A. Cornejo (11636656)

Flow diagram of the study. by Yoonjee Cho (15453454)

Subjects:

Correlation between the area under the threshold of the serum albumin curve up to POD 5 and the Sequential Organ Failure Assessment score on POD 5 (Spearman’s ρ = 0.32; P < 0.001).... by Yoonjee Cho (15453454)

Subjects:

Postoperative outcomes after living-donor liver transplantation after propensity score matching. by Yoonjee Cho (15453454)

Subjects:

Example of calculating the area under the threshold of the serum albumin curve up to postoperative day 5 (preset threshold = 3.0 g/dL). by Yoonjee Cho (15453454)

Subjects:

Baseline characteristics of patients. by Yoonjee Cho (15453454)

Subjects:

Combined decitabine and Taxol decreases MCF-7/Taxol cells proliferation and can improve their chemosensitivity. by Weihua Gong (471435)

Changes in POMS scores of the winter-over expeditioners. by Shiying Liu (1569478)

Subjects:

Alterations in CBC parameters in albino rats of both genders after 60 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level. by Nida Saleem (17194610)

Subjects:

Alterations in CBC parameters in albino rats of both genders after 30 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level. by Nida Saleem (17194610)

Subjects:

Alterations in CBC parameters in albino rats of both genders after 90 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level. by Nida Saleem (17194610)

Subjects:

Descriptive statistics (mean [standard deviation] or % [sample size]) for study variables analyzed in the current study. by Angelina R. Sutin (9216456)

Subjects:

Estimated marginal means of the RMS per muscle, based on the linear mixed-effects model. by I. Moll (14227650)

Subjects:

Estimated marginal means of the MF per muscle, based on the linear mixed-effects model. by I. Moll (14227650)

Subjects:

Trends in the prevalence of dyslipidemia in patients with type 2 diabetes. by Amirhossein Yadegar (13922190)

Subjects:

S1 Dataset - by Amirhossein Yadegar (13922190)

Subjects:

The success rate for blood lipid goals achievement, including TG<150 mg/dl, TC<200 mg/dl, LDL-C<70 mg/dl, and non-HDL-C<130 mg/dl. by Amirhossein Yadegar (13922190)

Subjects:

The baseline characteristics of the studied patients. by Amirhossein Yadegar (13922190)

Subjects: